The new trial makes mRNA vaccines personalized, taking an individual’s unique tumor cells. Seven out of the study’s eight ...

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

Moderna has begun a large-scale clinical trial of its mRNA-based bird flu vaccine, enrolling about 4,000 adults in the U.S. and U.K. The move follows earlier promising safety and immune response data ...

Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat. CAMBRIDGE, MA / ACC ...

Promega authorizes UBC RNA & Formulation Core to distribute NanoLuc-encoding mRNA, expanding researcher access for LNP and ...

This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

A new effort to prepare for future avian influenza outbreaks is moving forward despite a major funding setback.

The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...

Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...